Extra Control
TEXT
A
A
A

Talk to your doctor about how morning blood sugar (FPG), after-meal blood sugar (PPG), or both, can affect your A1C level.

Your doctor may recommend that you
measure your blood sugar in the morning
and after meals using a meter. The reading
you take in the morning before you eat is called
your FPG or fasting number. This reading will
help you and your doctor better understand how
well your blood sugar is being controlled when
you haven't eaten in a while.

Another important reading to take is your PPG
or after-meal number. Everyone's blood sugar spikes after they eat. But if you have type 2 diabetes, it may spike too high, a signal that you need more control.

Morning blood sugar (FPG), after-meal blood sugar (PPG), or both, can affect your A1C level.

A1C reflects a 3-month average of your blood sugar. This reading is done at your doctor's office or at a lab. Your doctor will use the results from your A1C test as well as your before-meal and after-meal readings to help manage your type 2 diabetes. If your doctor thinks your after-meal or morning blood sugar or your A1C levels are too high, your doctor may need to adjust your current treatment or add another medication to your current oral diabetes medicine.

The American Diabetes Association recommends an A1C of under 7

Make sure you talk to your doctor about your goals for your morning blood sugar (FPG), your after-meal blood sugar (PPG) and your A1C, and how you can best achieve them.

Onglyza (saxagliptin) may help you achieve better blood sugar control

In clinical studies, Onglyza lowered A1C, morning blood sugar (FPG), after-meal blood sugar (PPG) when added to one of several common oral diabetes medicines: metformin, a sulfonylurea, or a thiazolidinedione (TZD). If you have allergic (hypersensitivity) reactions, such as rash, hives, and swelling of the face, lips and throat, stop taking ONGLYZA and call your healthcare provider right away.

When Onglyza is used with certain other diabetes medicines to treat high blood sugar, such as a sulfonylurea or insulin, the risk of low blood sugar (hypoglycemia) is higher. Symptoms of low blood sugar include shaking, hunger, sweating, headache, rapid heartbeat, change in mood, and change in vision. Follow your doctor’s instructions for treating low blood sugar.

When Onglyza is used with a thiazolidinedione (TZD), such as pioglitazone or rosiglitazone, to treat high blood sugar, peripheral edema (fluid retention) may become worse. If you have symptoms of peripheral edema, such as swelling of hands, feet, or ankles, call your doctor.

The Value Card Program for Onglyza
Easy and instant savings for eligible patients.

Talk to Your Doctor
Need help talking with your doctor about type 2 diabetes? The Doctor Discussion Guide can help.

IMPORTANT SAFETY INFORMATION
for ONGLYZA (saxagliptin)

Do not take ONGLYZA (saxagliptin) if you are allergic to any of its ingredients. Serious allergic reactions can occur with ONGLYZA and may include swelling of the face, lips or throat, difficulty swallowing or breathing, swelling of the skin, hives, rash, itching, flaking, or peeling. If you have these symptoms, stop taking ONGLYZA and contact your doctor right away.

Serious side effects can happen to people taking ONGLYZA, including inflammation of the pancreas (pancreatitis) which may be severe and lead to death. Before taking ONGLYZA, tell your doctor if you ever had pancreatitis, gallstones, history of alcoholism, or high triglyceride levels. Stop taking ONGLYZA and contact your doctor right away if you have pain in your stomach area (abdomen) that is severe and will not go away. The pain may be felt going from your abdomen through to your back. The pain may happen with or without vomiting. These may be symptoms of pancreatitis.

WHAT IS ONGLYZA?

ONGLYZA (saxagliptin) is a prescription medicine used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.

ONGLYZA should not be used to treat people with type 1 diabetes or diabetic ketoacidosis (increased ketones in the blood or urine).

If you have had inflammation of the pancreas (pancreatitis), it is not known if you have a higher chance of getting pancreatitis while taking ONGLYZA.

When ONGLYZA is used with certain other diabetes medicines to treat high blood sugar, such as a sulfonylurea or insulin, the risk of low blood sugar (hypoglycemia) is higher. Symptoms of low blood sugar include shaking, hunger, sweating, headache, rapid heartbeat, change in mood, and change in vision. Follow your doctor’s instructions for treating low blood sugar.

When ONGLYZA is used with a thiazolidinedione (TZD), such as pioglitazone or rosiglitazone, to treat high blood sugar, peripheral edema (fluid retention) may become worse. If you have symptoms of peripheral edema, such as swelling of hands, feet, or ankles, call your doctor.

The most common side effects with ONGLYZA include upper respiratory tract infection, urinary tract infection, and headache.

Your doctor should test your blood to measure how well your kidneys are working before and during treatment with ONGLYZA. You may need a lower dose if your kidneys are not working well.

Tell your doctor if you start or stop taking other medications, including antibiotics, antifungals or HIV/AIDS medications, as your doctor may need to change your dose of ONGLYZA.

Tell your doctor if you are pregnant, breast-feeding, or plan to become pregnant or breast-feed.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please click here for Medication Guide, and click here for US Full Prescribing Information for ONGLYZA (saxagliptin).

This product information is intended for US customers only.
ONGLYZA® is a trademark of Bristol-Myers Squibb Company. ©2012 Bristol-Myers Squibb Company.
422US12WA13301 08/12 2028900

US Full Prescribing Information   Medication Guide  Unsubscribe  Privacy Statement  Legal Notice   Site Map

BMS Logo AstraZeneca Logo

Bristol-Myers Squibb Patient Assistance Foundation:
This non-profit organization provides assistance to
qualifying patients with financial hardship who generally
have no prescription insurance. Contact 1-800-736-0003
or visit www.bmspaf.org for more information.